Jason Tejani
General Counsel & Corporate Secretary Enveda Therapeutics, Inc.
Seminars
Thursday 6th August 2026
Panel Discussion: Ensuring Cross-Functional Alignment to Safeguard IP Defensibility & Preserve Enterprise Value
10:45 am
- Strengthening collaboration between scientific, regulatory and legal teams to support robust patent scope and resilient trade-secret protection
- Coordinating disclosure timing, data generation, and regulatory positioning to strengthen valuation, diligence readiness, and lifecycle strategy
- Reducing downstream enforcement, inventorship, and documentation risk in an increasingly AI-enabled R&D environment
Thursday 6th August 2026
Accelerating FDA Submissions Through AI-Assisted Module Drafting to Reduce Risk & Enhance Regulatory Efficiency
9:15 am
- Shortening submission timelines and expanding legal and regulatory capacity by embedding AI into FDA module drafting for a live Phase 2 asset
- Mitigating hallucination, confidentiality, and trade-secret exposure through structured guardrails, validation workflows, and disciplined human oversight
- Demonstrating measurable ROI through a real-world implementation with an external AI partner while preserving defensibility and data integrity
